United States: AstraZeneca's Challenge To Price Negotiation Fails In Federal District Court - Hyman, Phelps, & McNamara
Published
Last Friday, the Delaware District Court rejected AstraZeneca's lawsuit against the Medicare Drug Price Negotiation Program enacted under the Inflation Reduction Act (IRA) and CMS's guidance implementing it.
Full Article